Literature DB >> 33253609

Collaborative efforts are needed among the scientific community to advance the adverse outcome pathway concept in areas of radiation risk assessment.

Vinita Chauhan1, Daniel Villeneuve2, Donald Cool3.   

Abstract

Disease prevention and prediction have led to the generation of phenotypically based methods for deriving the limits of safety across toxicological disciplines. In the ionizing radiation field, human data has formed the basis of the linear-no-threshold (LNT) model for risk estimates. However, uncertainties around its accuracy at low doses and low dose-rates have led to passionate debates on its effectiveness to derive radiation risk estimates under these conditions. Concerns arise from the linear extrapolation of data from high doses to low doses, below 0.1 Gy where there is considerable variability in the scientific literature. Efforts to address these controversies have led to a mountain of mechanistic data to improve the understanding of molecular and cellular effects related to phenotypic changes. These data provide fragments of information that have yet to be combined and used effectively to improve modeling, reduce uncertainties, and update radiation protection approaches. This paper suggests a better consolidation of mechanistic research may serve to guide priority research and facilitate translation to risk assessment. An effective approach that may be implemented is the organization of data using the adverse outcome pathway (AOP) framework, a programme that has been launched by the Organization for Economic Cooperation and Development in the chemical toxicology field. The AOP concept has proved beneficial to human health and ecological toxicological fields, demonstrating possibilities for better linkages of mechanistic data to phenotypic effects. A similar approach may be beneficial to the field of radiation research. However, for this to work effectively, collaborative efforts are needed among the scientific communities in the area of AOP development and documentation. Studies will need to be evaluated, re-organized and integrated into AOPs. Here, details of the AOP approach and areas it could support in the radiation field are discussed. In addition, challenges are highlighted and steps to integration are outlined. Organizing studies in this manner will facilitate a better understanding of our current knowledge in the radiation field and help identify areas where more focused work can be undertaken. This will, in turn, allow for improved linkage of mechanistic data to human relevance and better support radiation risk assessments.

Entities:  

Keywords:  Adverse outcome pathway framework; adverse outcome; key events; low dose; radiation risk assessment

Mesh:

Year:  2021        PMID: 33253609      PMCID: PMC8312481          DOI: 10.1080/09553002.2020.1857456

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  20 in total

Review 1.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

2.  Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.

Authors:  Richard A Becker; Gerald T Ankley; Stephen W Edwards; Sean W Kennedy; Igor Linkov; Bette Meek; Magdalini Sachana; Helmut Segner; Bart Van Der Burg; Daniel L Villeneuve; Haruna Watanabe; Tara S Barton-Maclaren
Journal:  Regul Toxicol Pharmacol       Date:  2015-04-08       Impact factor: 3.271

3.  Extracting and Benchmarking Emerging Adverse Outcome Pathway Knowledge.

Authors:  Nathan L Pollesch; Daniel L Villeneuve; Jason M O'Brien
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

4.  Risk of lung adenocarcinoma from smoking and radiation arises in distinct molecular pathways.

Authors:  Noemi Castelletti; Jan Christian Kaiser; Cristoforo Simonetto; Kyoji Furukawa; Helmut Küchenhoff; Georgios T Stathopoulos
Journal:  Carcinogenesis       Date:  2019-10-16       Impact factor: 4.944

5.  Advancing the adverse outcome pathway framework-An international horizon scanning approach.

Authors:  Carlie A LaLone; Gerald T Ankley; Scott E Belanger; Michelle R Embry; Geoff Hodges; Dries Knapen; Sharon Munn; Edward J Perkins; Murray A Rudd; Daniel L Villeneuve; Maurice Whelan; Catherine Willett; Xiaowei Zhang; Markus Hecker
Journal:  Environ Toxicol Chem       Date:  2017-06       Impact factor: 3.742

Review 6.  Radiation Risk to the Fluoroscopy Operator and Staff.

Authors:  Cosette M Stahl; Quinn C Meisinger; Michael P Andre; Thomas B Kinney; Isabel G Newton
Journal:  AJR Am J Roentgenol       Date:  2016-10       Impact factor: 3.959

7.  AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.

Authors:  Maureen E Pittman; Stephen W Edwards; Cataia Ives; Holly M Mortensen
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-14       Impact factor: 4.219

Review 8.  The linear nonthreshold (LNT) model as used in radiation protection: an NCRP update.

Authors:  John D Boice
Journal:  Int J Radiat Biol       Date:  2017-06-14       Impact factor: 2.694

9.  Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas.

Authors:  Martin Selmansberger; Jan Christian Kaiser; Julia Hess; Denise Güthlin; I Likhtarev; Victor Shpak; Mykola Tronko; Alina Brenner; Michael Abend; Maria Blettner; Kristian Unger; Peter Jacob; Horst Zitzelsberger
Journal:  Carcinogenesis       Date:  2015-05-08       Impact factor: 4.944

10.  How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology.

Authors:  Clemens Wittwehr; Hristo Aladjov; Gerald Ankley; Hugh J Byrne; Joop de Knecht; Elmar Heinzle; Günter Klambauer; Brigitte Landesmann; Mirjam Luijten; Cameron MacKay; Gavin Maxwell; M E Bette Meek; Alicia Paini; Edward Perkins; Tomasz Sobanski; Dan Villeneuve; Katrina M Waters; Maurice Whelan
Journal:  Toxicol Sci       Date:  2016-12-19       Impact factor: 4.849

View more
  1 in total

Review 1.  Review of Knowledge of Uranium-Induced Kidney Toxicity for the Development of an Adverse Outcome Pathway to Renal Impairment.

Authors:  Yann Guéguen; Marie Frerejacques
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.